Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Study of Niraparib in First-Line Maintenance Therapy for Advanced Epithelial Ovarian Cancer and the Establishment and Promotion of Its Standardized Application System

NCT07783022 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07783022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07783022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Study of Niraparib in First-Line Maintenance Therapy for Advanced Epithelial Ovarian Cancer and the Establishment and Promotion of Its Standardized Application System
Lead sponsor
Fudan University
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2024
Completion date
November 30, 2027
Enrollment
1,920 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer